The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2569–2592 of 3,535
Kymera Therapeutics has received Fast Track designation from the FDA for its investigational oral drug, KT-621, a first-in-class STAT6 degrader targ...
Ocular Therapeutix has presented compelling post-hoc analyses from the SOL-1 Phase 3 trial of AXPAXLI (OTX-TKI) at the 14th Annual Vit-Buckle Society Me...
OXB has launched a fast-track development and manufacturing service aimed at biotechs facing timeline constraints, significantly accelerating the pathway to...
Spyre Therapeutics has announced promising results from the Phase 2 SKYLINE trial of SPY001, an investigational anti-α4β7 antibody designed to treat moderat...
ANI Pharmaceuticals, Inc. has launched Carbamazepine Extended-Release Capsules in 100 mg, 200 mg, and 300 mg dosages, marking a significant addition to its...
Jaypirca significantly improves survival without disease progression in CLL patients.
Lilly's Jaypirca (pirtobrutinib) has demonstrated a significant extension in progression-free survival (PFS) when combined with a venetoclax time-limite...
A recent investigation into the longevity effects of psilocybin use among humans highlights the complexities of translating findings from animal models to h...
In a recent study from the CALERIE trial, researchers applied proteomics to plasma samples from participants who achieved an average of 14% caloric restrict...
Research highlights significant sex differences in response to longevity interventions, emphasizing the need for tailored approaches. A comprehensive review...
A groundbreaking study from the Weizmann Institute of Science has redefined the genetic contribution to human lifespan, revealing that genetics may account...
Epitopea has appointed Dr. Lisa Butterfield to its Scientific Advisory Board, enhancing its expertise in cancer immunotherapy as it advances its RNA-based thera...
Epitopea has appointed Dr. Lisa Butterfield to its Scientific Advisory Board, enhancing its leadership in the development of RNA-based immunotherapies for solid...
Boehringer Ingelheim has introduced LENZELTA®, a novel vaccine designed to significantly reduce the incidence and severity of clinical mastitis in dairy cow...
The TANGENT study has demonstrated that emactuzumab, a targeted CSF-1R inhibitor, meets its primary and secondary endpoints with high statistical signif...
BioVersys, in collaboration with GSK and academic partners, has published pre-clinical data in Nature Communications on AlpE, a novel drug combination of...
The European Commission has approved Dupixent® (dupilumab) for the treatment of moderate-to-severe chronic spontaneous urticaria (CSU) in children aged 2 to...
A recent study from Queen Mary University of London has demonstrated that zilebesiran, an investigational drug, can significantly enhance blood pressure con...
Scientists at Stanford Medicine have identified a novel peptide, BRP, that mimics the appetite-suppressing effects of semaglutide (Ozempic) but with fewer s...
New research links specific genes to Parkinson’s disease risk, highlighting the need for further study.
CAPHRA (Coalition of Asia Pacific Tobacco Harm Reduction Advocates) is advocating for a critical reassessment of Bangladesh's proposed 2025 ban on vaping and ot...
Researchers at Rutgers University have unveiled compelling evidence that resonance breathing, characterized by a controlled rhythm of approximately six br...
A recent study published in JAMA Network Open by a research team led by Yoni Ashar has unveiled promising insights into the treatment of chronic back pain t...
A recent study from Stanford Medicine has identified genetic variants linked to a phenomenon termed GLP-1 resistance, which may explain why approximatel...
